Ebglyss 250mg Prefilled Pen Solution for Atopic Dermatitis

Ebglyss provides targeted relief for adults and adolescents aged 12 and older suffering from moderate-to-severe atopic dermatitis. This solution is specifically formulated for subcutaneous injection, offering an effective option when topical therapies are insufficient. Each prefilled pen simplifies the administration process for consistent dosing in your treatment routine. It is designed to help manage eczema symptoms effectively, providing a pathway to clearer, more comfortable skin. Consult with your healthcare provider to determine if this biologic therapy is the right choice for your specific health needs.

Active Ingredient: Lebrikizumab
Dosage: 250 mg
Volume: 2 ml
Form: Prefilled Pen
Route of Administration: Subcutaneous Injection
Indication: Moderate-to-Severe Atopic Dermatitis
Target Age: 12+ years
Minimum Weight Requirement: 40 kg